Advanced Biomed (ADVB) Gains from Investment Securities (2024 - 2026)

Advanced Biomed (ADVB) posted Gains from Investment Securities of -$1297.0 for Q1 2026, down 119.63% sequentially from $6608.0 in Q4 2025.

Advanced Biomed (ADVB) Gains from Investment Securities (2024 - 2026) Analysis & Trends

Advanced Biomed (ADVB) has 3 years of Gains from Investment Securities data on file, last reported at -$1297.0 in Q1 2026.

Quarterly Gains from Investment Securities changed N/A year-over-year to -$1297.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12501.0 (changed N/A YoY) and the FY2025 annual result came in at $83027.0, up 247.93% from the prior year.
Gains from Investment Securities retreated to -$1297.0 in Q1 2026 per ADVB's latest filing, from $6608.0 in the prior quarter.
The five-year high for Gains from Investment Securities was $6608.0 in Q4 2025, with the low at -$9555.0 in Q2 2024.
Average Gains from Investment Securities over 3 years is -$2582.0, with a median of -$1297.0 recorded in 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Advanced Biomed	6.22 Mn	6.22 Mn	-

Download Data